XIST could engage in TGF-β-induced epithelial-mesenchymal transition (EMT) and cell invasion and metastasis in non-small-cell lung cancer (NSCLC) [55] and colorectal cancer (CRC) [56]. The gene discussed is XIST; the disease is colorectal cancer.